Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Phosphodiesterase inhibitors discovered at Ortho-McNeil

Nov. 28, 2002

Chemokine CXCR3 antagonists designed by Millennium and Kyowa Hakko

Nov. 27, 2002

Canadian approval for Thymoglobulin in renal transplant patients

Nov. 27, 2002

Japan Energy and Sumitomo describe new immunomodulators for cancer and other disorders

Nov. 26, 2002

Cannabinoid CB2 receptor modulators under study at Shionogi

Nov. 22, 2002

Cytos and Medarex collaborate for new drug targets in immunological diseases

Nov. 18, 2002

Myfortic receives first major approval in Switzerland

Nov. 8, 2002

Novel triptolide prodrugs and their use in cancer and autoimmune diseases

Nov. 8, 2002

LF-15-0195 induces long-term heart allograft survival in rat model

Nov. 4, 2002

Organ Recovery Systems cleared to market improved kidney perfusion solution

Nov. 4, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...